Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $75.09 | 5 | 77.3% |
| Food and Beverage | $22.10 | 1 | 22.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $63.38 | 4 | $0 (2020) |
| Insulet Corporation | $22.10 | 1 | $0 (2024) |
| Lilly USA, LLC | $11.71 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.10 | 1 | Insulet Corporation ($22.10) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2020 | $19.89 | 1 | PFIZER INC. ($19.89) |
| 2019 | $31.69 | 2 | PFIZER INC. ($31.69) |
| 2018 | $11.80 | 1 | PFIZER INC. ($11.80) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $22.10 | General |
| Category: Insulin Pump | ||||||
| 06/24/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 02/07/2020 | PFIZER INC. | SOMAVERT (Drug) | Education | In-kind items and services | $19.89 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 10/28/2019 | PFIZER INC. | SOMAVERT (Drug) | Education | In-kind items and services | $19.89 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 01/09/2019 | PFIZER INC. | SOMAVERT (Drug) | Education | In-kind items and services | $11.80 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 09/17/2018 | PFIZER INC. | SOMAVERT (Drug) | Education | In-kind items and services | $11.80 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,016 | 4,712 | $244,351 | $135,408 |
| 2022 | 14 | 1,091 | 5,675 | $266,763 | $147,214 |
| 2021 | 13 | 857 | 4,852 | $251,762 | $143,066 |
| 2020 | 11 | 940 | 4,396 | $239,917 | $119,767 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 32 | 3,360 | $84,000 | $60,923 | 72.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 420 | 686 | $109,760 | $56,937 | 51.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 117 | 188 | $12,220 | $4,743 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $9,860 | $4,730 | 48.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 312 | 312 | $15,912 | $2,781 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 16 | $3,456 | $1,966 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $2,996 | $1,486 | 49.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 19 | $1,957 | $1,139 | 58.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 32 | 58 | $3,409 | $596.68 | 17.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 11 | $781.00 | $104.72 | 13.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 56 | 4,380 | $109,500 | $72,874 | 66.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 430 | 641 | $102,560 | $52,978 | 51.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 37 | 37 | $10,730 | $5,815 | 54.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 76 | 104 | $6,760 | $2,597 | 38.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 276 | 277 | $14,127 | $2,526 | 17.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $3,672 | $2,164 | 58.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 33 | 35 | $3,605 | $2,048 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 28 | $2,996 | $1,691 | 56.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,717 | $1,101 | 40.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 13 | $2,080 | $1,058 | 50.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 13 | 13 | $1,027 | $887.74 | 86.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 60 | 77 | $4,525 | $825.00 | 18.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $476.00 | $382.34 | 80.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 27 | 28 | $1,988 | $268.06 | 13.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 413 | 699 | $111,840 | $61,029 | 54.6% |
About Dr. Shannon Oates, MD
Dr. Shannon Oates, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235198342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Oates, MD has received a total of $97.19 in payments from pharmaceutical and medical device companies, with $22.10 received in 2024. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Education" ($75.09).
As a Medicare-enrolled provider, Oates has provided services to 3,904 Medicare beneficiaries, totaling 19,635 services with total Medicare billing of $545,455. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Lafayette, IN
- Active Since 03/20/2006
- Last Updated 02/03/2021
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1235198342
Products in Payments
- SOMAVERT (Drug) $63.38
- Omnipod (Device) $22.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Lafayette
Dr. Justin Fontenot, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $502,420
Dona Gray, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $206,781
Dr. Bennett Baquet, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,139
Daniel Stout, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $24,772
Dr. Ghyass Rizk, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $20,892
Dr. Laura Wolsko, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $23.31